Skip to content

Pulse Biosciences, Inc. PLSE Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.85M-4.4%
ITG
Integer HoldingsITGR
$2.45M-0.1%
LivaNova logo
LivaNovaLIVN
$2.73M-32.3%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$204K-8.9%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s non-cash lease expense?
Pulse Biosciences, Inc. (PLSE) reported non-cash lease expense of $308K in Q1 2026.
How has Pulse Biosciences, Inc.'s non-cash lease expense changed year-over-year?
Pulse Biosciences, Inc.'s non-cash lease expense increased by 12.4% year-over-year, from $274K to $308K.
What does non-cash lease expense mean?
Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.